Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MBIO - Mustang Bio Looks To Change Scope Of Treatment For Bubble Boy Disease


MBIO - Mustang Bio Looks To Change Scope Of Treatment For Bubble Boy Disease

Mustang Bio (MBIO) surged higher the prior week, after it highlighted substantially positive data in a phase 1/2 study using its gene therapy to treat patients with X-linked severe combined immunodeficiency ((XSCID)). It was shown that treatment with MB-107 was able to restore the immune system for these patients with the disease. This bodes well for the biotech's gene therapy program, as long as data can continue to be reproduced in a larger group of patients. Mustang Bio's gene therapy program is only a small part of its pipeline, because the other larger

Read more ...

Stock Information

Company Name: Mustang Bio Inc.
Stock Symbol: MBIO
Market: NASDAQ
Website: mustangbio.com

Menu

MBIO MBIO Quote MBIO Short MBIO News MBIO Articles MBIO Message Board
Get MBIO Alerts

News, Short Squeeze, Breakout and More Instantly...